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Glomerular response mechanisms to glycemic changes in insu-
lin—dependent diabetics. Glomerular filtration rate (GFR) and renal
plasma flow (RPF) were measured by constant inulin and PAH infusion
during euglycemia and intravenous dextrose—induced moderate hyper-
glycemia in seven insulin—dependent diabetics with persistently ele-
vated GFR, seven diabetics with normal GFR, and in six normal control
subjects. In euglycemia, RPF was higher and calculated renal vascular
resistance (RVR) lower in the hyperfiltering than the normofiltering
group (P < 0.05 for both variables), but filtration fraction (FF) was
similar in all groups. During hyperglycemia, mean GFR rose signifi-
cantly from 157 20 to 174 30 mllmin/1.73 m2 (11.9%; P < 0.05) in
the hyperfiltering group only. There was no statistically significant
change in mean GFR in the normofiltering diabetic (116 6 vs. 114
13 ml/min/l.73 m2) and the normal control groups (117 15 vs. 113
14 mllmin/l.73 m2). RPF and FF rose by 5.8% and 9.2%, respectively,
in the hyperfiltering group only, with no change in the normofiltering or
normal control groups. No change in RVR was found in any group.
Total tubular sodium reabsorption was higher during euglycemia in the
hyperfiltering diabetics (P < 0.01), and rose significantly during
hyperglycemia (P < 0.05) in this group only. Overnight euglycemia did
not remove the increased glomerular filtration and flow of hyperfiltering
diabetics. Hyperglycemia further accentuated hyperfiltration by elevat-
ing renal plasma flow and filtration fraction.
There is evidence that glomerular hemodynamic perturba-
tions with increased glomerular filtration rate (GFR) and raised
intraglomerular pressure can markedly influence the natural
history of the pathological lesions of diabetic and other
glomerulopathies [1—4].
A high GFR has been known to occur in a proportion of
young onset diabetics for many years [5, 6], and recent studies
suggest that diabetic patients who have elevated GFR lose
glomerular function at a faster rate than those with normal
GFR, and progress to diabetic renal failure [7]. The mechanisms
behind this hyperfiltration, however, remain largely unex-
plained [8—14].
The role of plasma glucose concentration itself in the induc-
tion and maintenance of the hyperfiltration has been the object
of several studies; however, results remain controversial and no
study to date has explored the mechanisms of glucose—induced
hyperfiltration in man. Different workers have demonstrated an
increase [15—17], a decrease [18] or no change in GFR 119] using
various techniques of raising plasma glucose. Some workers
have consistently failed to find any correlation between plasma
glucose concentration and GFR [20], while others have found a
significant correlation, although only in patients without severe
hyperglycemia [21]. In this latter report, blood glucose values
greater than 14 mmollliter were not associated with elevated
GFRs.
Findings from previous studies in our Unit have suggested
that the renal response to external stimuli, such as moderate
hyperglycemia, may be different between diabetic individuals.
The same blood glucose levels have, in fact, been found to be
associated with high GFR in some but normal GFR in other
patients [21]. In this study we have investigated the effect of
glucose infusion and the determinants of glucose—induced
glomerular hemodynamic changes in subsets of insulin—depend-
ent diabetics with and without persistent glomerular hyperfil-
tration.
Methods
Diabetic subjects were all deemed clinically to be insulin—
dependent and were recruited from the Diabetic Clinic at Guy's
Hospital, London; a group of healthy volunteers from the
Medical Staff at Ospedale S. Raffaele, Milan, served as con-
trols. Diabetics were screened for GFR using 51Cr EDTA
clearance in order to identify hyperfiltering patients. Normal
values using this technique in our laboratory range between 84
and 135 mllmin/1.73 m2 [21]. Subjects were all male and were
excluded if they were aged less than 16 or greater than 50 years,
had diabetes for a duration less than 1 or greater than 20 years
(if applicable), known cardiovascular or renal tract disease, or
arterial hypertension (blood pressure >160/95 mm Hg), were
greater than 110% of ideal body weight, or were receiving any
medication other than insulin. No attempt was made to alter the
previous diet or glycemic control of diabetic subjects who were
all in good nutritional status. All subjects gave informed con-
sent to the study which was approved by both local ethical
committees. Relevant clinical data are given in Table 1.
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Experimental design
Glucose infusion. Diabetic patients were admitted to a Met-
abolic Ward at 6:00 p.m. Insulin was infused through an
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Table 1. Clinical data
Body
N Ageyrs
Diabetes
duration,
yrs
Blood
pressure
mm/Hg
surface
area,
m2
Hyperfiltering
diabetics 7 26.1 4.7 9.3 2.3 112.5 5.5
76.5 6.0
1.84
Normofiltering
diabetics 7 28.4 7.2 9.6 5.8 115.1 11.2
77.1 7.1
1.86
Controls 6 26.6 2.1 — 117.5 6.8
74.1 5.8
1.91
Figures are mean SD.
antecubital vein and adjusted to maintain overnight euglycemia
(mean insulin infusion rate 0.86, range 0.5 to 2.0 U/hr). The next
morning after baseline measurements of renal function a graded
infusion of dextrose 50 g!dl was given (total 37 mll/l.73 m2 over
20 mm) according to the method of De Fronzo, Tobin and
Andres [22] to raise plasma glucose by approximately 7
mmollliter. The levels of blood glucose obtained were chosen to
be in the range of moderate hyperglycemia which, in previous
studies [21], was shown to be associated with high GFR.
Hyperglycemia was maintained by continuous adjustment of
dextrose infusion rate (range 10 to 42, mean 28, ml/hr) based on
frequent measurements of blood glucose. The insulin infusion
rate remained unchanged. Renal function was then assessed
during hyperglycemia.
Normal control subjects were admitted fasting on the morn-
ing of the test and were connected to an artificial beta cell
(Biostator, Ames, Elkhart, Indiana, USA) for intravenous
feedback control of blood glucose. After baseline measure-
ments of renal function in euglycemia, plasma glucose was
raised to and clamped at approximately 10 mmollliter. The
constants used for algorithms were KR = 145, KF = 45, QI =
50, B! = 300, RI = 12, Fl = 200, BD 200, RD = 100, QD
5, FD = 400; the run mode was 3:1.
All subjects were fasted from 10:00 p.m. the previous night
and alcohol, tea, coffee or any drink other than tap water was
prohibited. Sodium intake was unrestricted and no attempts
were made to manipulate the diet prior to the study.
Kidney function measurements. GFR and renal plasma flow
(RPF) were measured using the constant infusion technique for
inulin and sodium paraaminophippurate (PAH) during a steady
state of water diuresis [23]. Subjects drank 1.5 liter of tap water
between 7:00 and 8:00 a.m. and 200 ml every 20 minutes
throughout the study. Following bolus injection of 600 mg PAH
and 3.5 g inulin, a sustaining infusion of PAH at 14 mg/mm and
inulin at 40 mg/mm in normal saline (9 g/dl) at 60 mi/mm was
given. After 40 minutes equilibration, four 20 minute, baseline
clearance measurements were made. Twenty minutes after
elevation of blood glucose concentrations four further 20
minute measurements were taken during sustained hypergly-
cemia. The means of all four periods for each patient during
euglycemia or hyperglycemia were used for calculation; the 20
minute period during elevation of plasma glucose levels was
discarded. Subjects remained supine throughout the test, stand-
ing only to void. Blood samples were taken at the mid—point of
each 20 minute urine collection period and pulse rate and
arterial blood pressure (phase I/V; standard mercury sphygmo-
manometer) were recorded at the same time. Urine volume was
measured, and immediately paired aliquots were diluted 1:5 in
distilled water for inulin assay. Concentrations of the following
were measured in plasma and urine: inulin and PAH by the
methods of Heyrovsky [24] and Bratton and Marshall [25],
respectively, glucose by a glucose oxidase method (Yellow
Springs Analyzer YSI 23 AM, Yellow Springs, USA), sodium,
potassium, creatinine and urea by Vickers Multichannel
Autoanalyzer. Plasma and urine osmolality were measured by
freezing point depression (Roebling Osmometer, Roebling In-
struments, Berlin, FRG). Plasma—free insulin concentration
was measured by radioimmunoassay [26], hematocrit by rou-
tine Coulter counter (Coulter Electronics, Hileah, Florida,
USA) and plasma proteins by refractometry. Renal vascular
resistance (RVR) was calculated as:
MBP x (l-Ht)
RPF
where MBP is mean blood pressure calculated as diastolic BP +
'/3 pulse pressure and Ht is hematocrit.
Free water clearance was calculated as VCsm where V is
urine flow rate, and Cosm is total osmolar clearance.
Interassay coefficients of variation for the inulin and PAH
assays were 6.8% and 5.2%, respectively. The correlation
coefficient between 51Cr EDTA and baseline inulin clearance
was 0.86 and the equation describing the regression line x =
1.02y + 0.22. No patient changed GFR category from screening
to test period. RPF was not determined for technical reasons in
one hyperfiltering and one normofiltering diabetic during
hyperglycemia.
Statistics
For comparisons between euglycemia and hyperglycemia in
any of the groups, the t-test or Wilcoxon's test for paired data
were used. For comparisons between the three groups, analysis
of variance and the Bonferroni adjusted t-test were used for
normally distributed data, and the Kruskal—Wallis one—way
ANOVA by ranks was used for non-parametrically distributed
data [27]. Correlations between variables were analyzed by
linear regression using the least squares method. Data are given
as mean SD.
Results
Plasma glucose, glomerular filtration rate, renal plasma flow,
filtration fraction and renal vascular resistance
After overnight insulin infusion similar levels of baseline
euglycemia were obtained in both diabetic groups, not differing
from that of the control subjects (Fig. 1). Despite this, both
GFR and RPF were significantly higher (P <0.002, P < 0.01,
respectively) in the hyperfiltering than the normofiltering and
normal control diabetic groups, but filtration fraction (FF) was
similar in all groups (Fig. 2, Tables 2 and 3). Calculated renal
vascular resistance (RVR) was significantly lower in the
hyperfiltering group than the normofiltering group (70.0 14.1
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vs. 101.0 29.2 mm Hg . mm/mi, P < 0.05). No measurement
of RVR was made in non-diabetic control subjects.
Glucose infusion raised plasma glucose concentration to the
same extent in the two diabetic groups, resulting in stable
hyperglycemia at 12.5 mmolliiter on average. In the control
subjects, plasma glucose was clamped at an average concentra-
tion of 9.8 mmollliter (Fig. 1). Sustained glucose—induced
hyperglycemia resulted in a significant increase of 11.9% (P <
0.05) in GFR in the diabetic patients with glomerular hyperfil-
tration but failed to change GFR significantly in the normofilter-
ing diabetics or in the control subjects (Fig. 2, Tables 2 and 3).
The change in GFR was significantly greater (P < 0.05) in the
hyperfiltering diabetics (mean + 17.6; range — 6 to + 82
ml/min/i .73 m2) than in the normofiltering diabetic (mean —2.1;
range — 13 to + 6 mlImin/l.73 m2) and in the control groups
(mean — 3.7; range —17 to + 10 ml/min/l.73 m2) in whom a net
fall was found. In the hyperfiltering diabetic group there were
rises in both RPF (5.8%) and FF (9.2%) which failed to reach
conventional levels of statistical significance, nor were there
any significant changes in the normal control or normofiltering
diabetic groups (Fig. 2, Tables 2 and 3). Renal vascular resist-
ance did not change significantly in the hyperfiltering group
(66.4 5.5 mm Hg. minlml) or in the normofiltering diabetics
(104.6 23.5 mm Hg. minlml). No significant correlation
between changes in RPF or FF and GFR were found in any
group.
Plasma free insulin, hematocrit and plasma proteins
Free insulin levels were similar during euglycemia in the two
diabetic groups but lower in the control subjects (P < 0.04).
During hyperglycemia free insulin levels did not change signif-
icantly in the diabetics but rose in the normal controls to levels
higher than that of the diabetic groups (Table 4).
In all three groups hematocrit and plasma protein concentra-
tions were similar during euglycemia, and fell after induction of
hyperglycemia (Table 4).
Urine flow, urinary glucose and urinary albumin
Urine flow rate fell significantly in all three groups during
glucose infusion (Table 5). Glycosuria was not detected in
either diabetic group during euglycemia or in the control group
throughout the study. Urinary glucose excretion during
hyperglycemia was similar in the hyperfiltering and normofilter-
ing diabetic groups (0.144 0.102 vs. 0.094 0.053
mmoLtmin/1 .73 m2). Maximum tubular transport capacity for
glucose (TmG) was calculated in the diabetic groups as filtered
load of glucose (plasma glucose concentration x GFR) minus
glucose excretion rate, and was significantly higher in the
hyperfiltering group than the normofiltering group (2.02 0.33
vs. 1.31 0.15 mmol/min/l.73 m2; P < 0.001). Furthermore, a
highly significant correlation was found between GFR and TmG
in both hyperfiltering (r = 0.94, P < 0.005) and normofiltering
groups (r = 0.89; P < 0.01).
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Fig. 1. Mean SDplasma glucose concentrations in the three groups
during four euglycemic and four hyperglycemic clearance periods.
Symbols are: (•—•) control; (A—A) normofiltenng diabetics;
(&.—L) hyperfiltering diabetics.
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Fig. 2. Mean SD glomerularfiltration rate (GFR), renal plasma flow(RPF) and filtration fraction (FF) during euglycemia (E) and
hyperglycemia (H) in hyperfiltering (is—A) and normofiltering dia-
betics (A—A), and in non-diabetic control subjects (—S). Only
data where paired comparisons were made are shown. Symbols are:
P < 0.05 compared to E and P < 0.002 compared to normofiltering
diabetics; *, P < 0.01 compared to normofiltering diabetics; **, P <
0.002 compared to normofiltering diabetics.
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Table 2. Glomerular filtration rate (GFR), renal plasma flow (RPF) and
filtration fraction (FF) during euglycemia (E) and hyperglycemia (H)
GF
ml/min/1
E
R
.73 m2
H
RPF
mllmin/l.73 m2
E H
FF
E H
Hyperfiltering
diabetics
1 161 155 842 740 0.191 0.209
2 156 162 636 — 0.245 —
3 200 206 855 956 0.234 0.215
4 141 152 603 625 0.231 0.243
5 142 154 928 921 0.153 0.167
6 149 161 488 627 0.305 0.257
7 147 229 693 720 0.212 0.318
(N=7)
157 l74 721 — 0.224 —
SD 20 31 159 0.047
(N =6)
735 765 0.221 0.235
SD 169 143 0.058 0.051
Normofiltering
diabetics
1 113 101 671 — 0.168 —
2 111 105 562 539 0.198 0.195
3 117 116 499 483 0.234 0.240
4 117 123 521 509 0.225 0.242
5 113 117 374 430 0.302 0.272
6 113 100 456 457 0.248 0.219
7 129 135 692 693 0.186 0.195
(N =7)
116 114 539 — 0.223 —
SD 6 13 114 0.045
(N= 6)
5t 517 519 0.232 0.227
SD 107 94 0.041 0.030
a P < 0.05 for H vs. E
Table 3. Glomerular filtration rate (GFR), renal plasma flow (RPF)
and filtration fraction (FF) in non-diabetic control subjects during
euglycemia (E) and hyperglycemia (H)
ml!
GFR
min/l.73 m2
RPF
mlfmin/1.73 m2 FF
Subject E H E H E H
1
2
3
4
5
6
128 132
120 116
117 100
93 103
106 101
135 127
667 687
536 474
601 555
571 613
501 564
579 562
0.192
0.224
0.195
0.163
0.212
0.233
0.192
0.245
0.180
0.168
0.179
0.226
x
SD
117
15
113
14
576 576
57 71
0.203
0.025
0.198
0.030
Plasma and urinary sodium, and free water clearance
During euglycemia plasma sodium concentration in the
hyperfiltering diabetics was similar to that of the normofiltering
diabetics (139.1 2.0 vs. 138.5 2.4 mmollliter) as was urinary
excretion of sodium (hyperfiltering diabetics 193 99
p.mollmin; normofiltering diabetics 213 123 prnollmin). How-
ever, total tubular reabsorption of sodium (calculated as filtered
Table 4. Hematocrit, plasma protein and plasma free insulin in the 3
groups during euglycemia (E) and hyperglycemia (H)
Plasma
Hematocrit
%
E H
protein
g/liter
E H
Plasma free
insulin tU/ml
E H
Hyperfiltering 42.5 415b 66 63 15.7 15.9
Diabetics ±2.1
Normofiltering 41.8 40.2a 67 63C 20.4 24.6
Diabetics
Normal 43.1 42.0c
±2.1
63 60 5,8d 28.Oa
a P < 0.001 compared to euglycemia
b P < 0.005 compared to euglycemia
P < 0.025 compared to euglycemia
d p < 0.04, normals vs. hyperfiltering and normofiltering diabetics.
Table 5. Urine flow, free water clearance and total sodium
reabsorption during euglycemia (E) and hyperglycemia (H)
Free water Total sodium
Urine flow clearance reabsorption
mI/mm mI/mm mmol/min
E H E H E H
Hyperfiltering 16.7 13.6a 12.8 9.1 21•6d 236c,d
Diabetics ±3.5
Normofiltering 13.8 11.8" 10.6 9.1 16.3 15.2
Diabetics
Normal 16.3 14.3c 11.8 11.0 15.6 15.1
Controls
a P < 0.005 compared to euglycemia
b P < 0.025 compared to euglycemia
P < 0.05 compared to euglycemia
d p < 0.002 compared to normofiltering diabetics and controls
load of sodium [plasma sodium concentration x GFR] minus
urinary sodium excretion) was significantly higher in the
hyperfiltering diabetics than the normofiltering diabetics (21.6
2.8 vs. 16.3 1.4 mmol/min; P < 0.002).
After induction of hyperglycemia, plasma sodium concentra-
tion fell slightly both in the hyperfiltering (136.7 3.5
mmollliter, P < 0.025) and the normofiltering diabetic groups
(135.1 2.2 mmol/liter, P < 0.001). Urinary excretion of
sodium showed a similar non-significant tendency to rise in the
hyperfiltering and normofiltering diabetic groups (225 96 and
221 82 mol/min). This was associated with a further increase
in total tubular sodium reabsorption in the hyperfiltering group
to 23.6 3.5 mmollmin (P < 0.05) and a tendency for this
variable to fall in the normofiltering group to 15.2 2.1
mmoLfmin (P> 0.1, Table 5).
In the control subjects during euglycemia, plasma sodium
was not significantly different from diabetics (136.4 2.1
mmollliter) and did not change during hyperglycemia. These
non-diabetic subjects excreted significantly less sodium during
aglycosuric, hyperglycemia than during euglycemia (175 101
vs. 225 120 /.Lmol/min; P < 0.005), although total sodium
reabsorption did not change (Table 5). Free water clearance
was similar in all groups at baseline, and fell significantly only in
the hyperfiltering diabetic group (Table 5) even though the
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actual values obtained during hyperglycemia were not different
between the three groups.
Blood pressure
Arterial pressure was similar in the three groups at screening
(Table 1). After hyperglycemia there was a small but significant
increase in systolic pressure in the hyperfiltering diabetics (P <
0.02), but no change in the normofiltering patients. However,
arterial pressure was not different between the two groups
either during euglycemia (hyperfiltering diabetics
110.4 10.1
75.1 7.1
mm Hg; normofiltering diabetics
114.6 7.6
76.1 5.9
mm Hg) or during hyperglycemia (hyperfiltering diabetics
116.1 8.5
76.3 6.5
mm Hg; normofiltering diabetics
115.6 9.4
mm Hg).
75.9 6.2
Pulse rate did not change in either the hyperfiltering (59.7
6.0 vs. 58.6 6.3 min') or the normofiltering group (56.0 5.8
vs. 55.7 6.7 min).
For technical reasons pulse rate and arterial pressure were
not measured during glucose clamping in normal controls.
Discussion
There are two main findings from this study. The first is that
diabetics found to be hyperfiltering under ordinary conditions of
life remain hyperfiltering despite overnight euglycemia. This is
in keeping with our previous findings that on average more than
three months of near normoglycemia are required to lower
elevated GFR into the normal range [28]. RPF was also higher
in these patients at baseline as demonstrated also by others [29]
but no difference in FF from normofiltering diabetics was found
under euglycemic conditions.
These data, combined with the finding of a low RVR,
demonstrate that an elevation of RPF and therefore a state of
hyperperfusion due to renal arteriolar vasodilatation is likely to
be responsible for the high GFR of hyperfiltering diabetics
during euglycemia. This suggests either that renovascular sen-
sitivity to glucose is increased in hyperfiltering diabetics, or that
factors other than ambient plasma glucose regulate the GFR in
these patients during euglycemia. A host of vasoactive sub-
stances or different glomerular reactivity to them may be
implicated. Such mediators of diabetic hyperfiltration remain
largely to be clarified [30].
The second finding is that the renal response of such
hyperfiltering subjects to an acute but moderate increase in
plasma glucose is not only quantitatively, but also, for the given
level of hyperglycemia in this study, qualitatively different from
that of normofiltering diabetics or control subjects. GFR in the
hyperfiltering diabetics rose significantly while the change in
normofiltering diabetics and controls was a net decline, albeit
not statistically significant. We cannot, however, exclude that if
different levels of glycemia had been aimed for and reached, the
response in any of the groups might have been different.
A different response to acute increases of blood glucose in
diabetic patients with different baseline GFR has not been
reported before. Christiansen, Frandsen and Parving have
reported a universal GFR rise averaging approximately 5% over
baseline values following glucose infusion and sustained
hyperglycemia for one to two hours both in normal and diabetic
subjects [15]. In this study most diabetics had baseline GFR
values within the normal range and only three displayed definite
glomerular hyperfiltration. However, not all authors have con-
firmed this. Mogensen found a small rise in four normal subjects
when plasma glucose was raised to approximately 16
mmollliter, but not in diabetic subjects [19]. Fox demonstrated
a rise in six of seven normal subjects [17], but Grimelli et al
failed to demonstrate a significant change in inulin clearance in
thirteen non-diabetic subjects; in these subjects renal plasma
flow, measured by PAH clearance, actually fell [31]. More
recently Blantz et at showed no change in basal GFR during
moderate hyperglycemia in the non-diabetic rat [32]. Although
the reasons for this difference between the hyperfiltering and
normofiltering subjects were not addressed in the design of this
study, some suggestions can be made based on the available
data. Under our experimental conditions the glucose—induced
GFR elevation in the hyperfiltering diabetics could not be fully
accounted for by the increase in RPF, and FF therefore also
rose. Changes in FF represent changes in those determinants of
GFR not accounted for by RPF, that is afferent artenolar
oncotic pressure, mean transglomerular hydraulic pressure
gradient (AP), and ultrafiltration coefficient (Kf) [33]. There was
a 4.5% fall in plasma protein concentration (Table 4), which is
the main contributor to oncotic pressure. This is in agreement
with the findings of Brochner—Mortensen [161. The remainder of
the increase in FF must arise from an increase in iSP, Kf, or a
combination of them. In the moderately hyperglycemic,
insulin—treated diabetic rat, a comparable situation (given the
species difference) to the present study, zP is found to be
elevated [34—36]. However, the ultrafiltration coefficient, K, is
not significantly different from normal [34—36]. Although in
humans it is impossible to differentiate these factors, our data
are consistent with the view that a rise in P may have
contributed to the augmented GFR in hyperfilterers during
moderate hyperglycemia. However, we cannot exclude the
possibility that changes in Kf might have occurred.
In contrast, in the normofiltering diabetics, renal hemody-
namics remained virtually unchanged in response to hypergly-
cemia, a finding similar to that in the normal controls. This
diversity cannot be accounted for by differences in the degree of
glycemia and glycosuria or by the fall in hematocrit and in
plasma protein concentration which were similar between the
two diabetic groups. There was, however, a clear difference in
tubular handling of sodium found in these two groups. During
hyperglycemia the TmG was significantly higher in the
hyperfiltering diabetics and this was associated with a commen-
surate elevation of total tubular sodium reabsorption, a finding
in agreement with a recent report by Brochner—Mortensen et al
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[37]. As nearly twice as much glucose was reabsorbed by the
hyperfiltering diabetics, it can be calculated that, at minimum,
a similar absolute increase in proximal tubular sodium—reab-
sorption must have occurred, as sodium is linked to glucose
reabsorption in the proximal tubule on a 1: 1 molar basis [38].
This could theoretically have led to a relative reduction in the
distal delivery of sodium to the macula densa and triggered the
sequence of events leading to an increase in GFR [391. The
increase in net sodium excretion in these subjects during
hyperglycemia, however, argues against it, and the increased
sodium reabsorption seen in the hyperfilterers may merely
reflect glomerular—tubular balance. As GFR increases, renal
sodium reabsorption would also increase, and this would not
lead to reduced distal delivery of sodium. Different studies of
combined lithium and sodium clearances would probably be
required to test whether the increased tubular reabsorptive
function is cause or effect of the increased GFR. In any event,
our data strongly suggest that the hyperfiltering kidney appears
intrinsically to reabsorb more sodium both under euglycemic
and hyperglycemic conditions. Insulin per se can increase
tubular sodium reabsorption [40], but insulin levels were similar
in the two diabetic groups and cannot therefore account for this
difference. The increased tubular reabsorptive capacity proba-
bly resides in the renal anatomical differences between these
groups. Hyperfiltering kidneys are bigger, with hypertrophic
nephrons having larger tubules with more and larger cells [41].
The response of the normal subjects to infused glucose is of
interest. This response is similar to that found in normofiltering
diabetics but is at variance with some previous reports [15, 17,
42]. The levels of glycemia obtained in our study were approx-
imately 1 mmollliter lower than those achieved in other studies
and none of our normal controls became glycosuric. In contrast
glycosuria was prominent in the studies of Ek [42], Fox et al
[17] and Christiansen, Frandsen and Parving [15; personal
communication]. In the study of Grimelli et al in which
hyperglycemia did not result in significant elevation of GFR,
glycosuria was not reported [31]. This may be of relevance as
glycosuria may influence tubulo-glomerular feedback re-
sponses. Blantz et al have shown that the normal, glomerular
vasoconstrictive response to increased distal tubular—flow is
blunted by glycosuria resulting in relative hyperfiltration [32].
Presence or absence of glycosuria may therefore explain the
difference between our and other workers' findings.
The universal fall in urine flow during hyperglycemia, to-
gether with the tendency for free water clearance to fall,
reaching significance only in the hyperfilterers, is consistent
with a rise in arginine vasopressin levels, possibly to a greater
degree in the group with glomerular hyperfiltration. The role of
changes in plasma concentrations of this hormone in the regu-
lation of plasma volume and glomerular vascular tone [43] as
possible mediators of the responses observed must, however,
remain speculative as specific measurements were not carried
out.
The present data suggest that hyperfiltering diabetics repre-
sent a sub-group whose renal response to ambient glucose is
both quantitatively and qualitatively different from normofilter-
ing diabetics. Moreover the determinants of the high GFR
appear to be different under euglycemic and hyperglycemic
conditions. Raised FF as well as RPF appear to occur only
during hyperglycemia. Elevated intraglomerular pressure may
contribute to the raised FF, and this condition may be poten-
tially more harmful to the kidney than increased flow alone, as
found during euglycemia [44]. It therefore becomes crucial
further to elucidate the mechanisms behind these abnormalities.
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